Neurofold Therapeutics Inc.

New Filing
CIK: 0002145237·Biotechnology·DELAWARE·Filed: Jul 14, 2026
Total Offering

$6,499,987

Amount Sold

$6,499,987

Investors

18

First Sale

Jun 25, 2026

Offering Details

Type
Equity, Other: SAFE (Simple Agreement for Future Equity)
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
Rajeev Kumar
Gurdane Bhutani

Company

Neurofold Therapeutics Inc.

5500 S. MARIGOLD COURT

GREENWOOD VILLAGE, CO, 80121

303-564-8817

SEC Filing

0002145237-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Neurofold Therapeutics Inc. Form D Filing — $6,499,987 | FilingFlow